Results 171 to 180 of about 25,866 (210)

Topotecan

Reactions Weekly
  +4 more sources

Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial

Journal of Clinical Oncology, 2021
Francisco Bautista, Xavier Paoletti, Jonathan Rubino   +2 more
exaly  

Topotecan

Reactions Weekly, 2013
openaire   +1 more source

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Journal of Clinical Oncology, 2005
David S Miller
exaly  

Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer

Journal of Clinical Oncology, 2007
Jean-Louis Pujol
exaly  

Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial

Lancet Oncology, The, 2016
Koichi Goto, Yuichiro Ohe, Makoto Nishio
exaly  

Topotecan

Reactions Weekly, 2018
openaire   +1 more source

Topotecan

Reactions Weekly, 2021
openaire   +1 more source

Topotecan

Reactions Weekly, 2011
openaire   +2 more sources

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Lancet Oncology, The, 2018
Radoslav Chekerov, Sven Mahner, Ahmed El-Balat   +2 more
exaly